drugset / Trial / NCT00120172
Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Currently there is no one standard of care for older patients with metastatic colorectal cancer. The study will examine the tumor response to capecitabine, oxaliplatin, plus bevacizumab. The study will also gather information on the usefulness and side effects of this treatment combination.
Timeline
- Start
- 2005-05
- Primary completion
- —
- Completion
- 2006-06
Outcome
Outcome not reported
Stopped: “positive results from a larger study with same regimen was released.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | — | — |
| Subject | Capecitabine | Small molecule | — | — |
| Subject | Oxaliplatin | Small molecule | — | — |